TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/23/2026
Back to search
Official data from USPTO
R
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
04/25/2026
Trademark type
Combined
Nice classes
5, 42
Filing date
04/12/2024
Registration date
09/16/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/16/2025
Last transaction
04/25/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
BE
Examiner
SMITH, CAROLINE P
Law office
M10
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of a stick figure man with the body shown in dark blue and an orange circle as the head.
Holders and representatives
Holders
Rejuvenate Biomed NV
Representatives
Cheryl L. Burbach Erise IP, P.A.
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicalbiologicalpharmaceutical preparations for the treatment of viral infectionsbacterial infectionscancerviralbacterialmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; veterinary preparations for petscattlelivestockfor the treatment of viral infectionsbacterial infectionscancerviralbacterialmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; medicalbiologicalpharmaceutical preparations for preventing and treating viralbacterialyeast infections; veterinary preparations for petscattlelivestockfor preventing and treating viralbacterialyeast infections; medicalbiologicalpharmaceutical preparations for preventing and treating cancermetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; veterinary preparations for petscattlelivestock for preventing and treating cancermetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; vaccines; sanitary preparations for medical purposes; dietary supplements and dietetic preparations adapted for medical purposes; dietetic foods adapted for medical use; diagnostic preparations for medical purposes; diagnostic chemical reagents for medical use; clinical medical reagents
Class 42
Biological research; clinical research in the field of age-related diseases and cancer; medical research; research and development services in the field of pharmaceutical preparations; pharmaceutical products development; pharmaceutical product evaluation; research and development in the field of microorganisms and cells; research on the subject of pharmaceuticals; testing of pharmaceuticals; laboratory research services relating to pharmaceutical product development; development of gene-based medicines; drug discovery services; scientific research in the nature of conducting clinical trials for others relating to pharmaceutical products; scientific laboratory services; laboratory research services relating to pharmaceuticals; scientific risk assessment being consultation in the field of health risk assessmentprediction and assessment of health risks to public and private agenciesfacilitiesindividuals and locations following an accidental or terrorist caused release of chemicalbiologicalradiological or nuclear materials; consulting services in the field of pharmaceutical research; testing of pharmaceuticals being services for assessing the efficiency of pharmaceuticals; pharmaceutical toxicity testing for research purposes; pharmaceutical toxicity analysis services for scientific research purposes; computer servicesremote management of the information technology (IT) systems of others for the pharmaceutical and healthcare industries; conducting early evaluations in the field of new pharmaceuticals; providing information about scientific researchthe results of clinical trials for pharmaceutical products; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; chemical research and analysis services; medical and pharmacological research services; scientific servicesscientific research in the field of genetics; scientific research for medical purposes in the field of age-related diseases and cancer; medical and scientific researchconducting clinical trials for others; scientific research in the field of genetics; genetic mapping for scientific purposes; DNA screening for scientific research purposes; providing scientific research information in the field of pharmaceuticals for the treatment of medical disorders; technical research in the field of pharmaceutical studies; veterinary research; design and development of computer software relating to the medical field; design and development of computer software relating to healthcare; computer programming in the medical field; scientific computer programming services; providing temporary use of non-downloadable software for capturingstoringprocessingevaluating and reproducing medical and pharmaceutical data; providing temporary use of on-line non-downloadable computer programs on data networks using artificial intelligence (AI) for use in the life sciences research fieldpharmaceutical researchmedical researchdrug discovery and development; platform as a service (PAAS) featuring computer software platforms using artificial intelligence (AI) for use in the life sciences research fieldpharmaceutical researchmedical researchdrug discovery and development; software as a service (SaaS) services featuring software for capturingstoringprocessingevaluating and reproducing medical and pharmaceutical data in the life sciences research fieldpharmaceutical researchmedical researchdrug discovery and development; software as a service (SaaS) featuring software using artificial intelligence (AI) for capturingstoringprocessingevaluating and reproducing medical and pharmaceutical data in the life sciences research fieldpharmaceutical researchmedical researchdrug discovery and development; software as a service (SaaS) featuring software using artificial intelligence (AI) for analysis of self-assessment of illnesses; software as a service (SaaS) featuring software using artificial intelligence (AI) for machine learning in the field of healthcare; software as a service (SaaS) featuring health monitoring software; software as a service (SaaS) featuring software for analyzing biological genetic data; technology consultation in the field of artificial intelligence (AI); research in the field of artificial intelligence (AI)
Publications
History of USPTO decisions and trademark events.
33 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/23/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/23/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/23/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/23/2026
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/16/2026
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/28/2026
FIMP
FINAL DISPOSITION PROCESSED
03/27/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/16/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
11/22/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/14/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
10/22/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
10/22/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/16/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
09/16/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/29/2025
PUBO
PUBLISHED FOR OPPOSITION
07/29/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/23/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/20/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/01/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/01/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/01/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/28/2025
RFNT
REFUSAL PROCESSED BY IB
11/23/2024
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
11/08/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/05/2024
RFRR
REFUSAL PROCESSED BY MPU
11/05/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/30/2024
CNRT
NON-FINAL ACTION WRITTEN
10/29/2024
DOCK
ASSIGNED TO EXAMINER
10/25/2024
MAFR
APPLICATION FILING RECEIPT MAILED
06/03/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/03/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/23/2024
Continuous trademark protection
Get notified about every new filing that threatens R or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.